Medable Achieved Top Status in Patient Engagement
Medable Inc., a pioneering technology platform for clinical trials, has recently been acknowledged for its outstanding contribution to patient engagement in the realm of clinical research. The recognition comes from the revered Everest Group, which named Medable as a 'Trailblazer' in its inaugural Clinical Trial Patient Engagement Products Assessment.
Significant Recognition Among Industry Peers
Coming out on top of 44 contenders, Medable stands out as the only organization to earn a perfect score across all assessed categories. This remarkable achievement underscores Medable's comprehensive approach to enhancing patient engagement throughout clinical trials, notably through its innovative Patient Caregiver Network (PCN). Established in 2018, the PCN has grown to incorporate nearly 100 patient advocates and caregivers from a diverse spectrum of backgrounds and health conditions.
Driving Change with Real Patient Feedback
Medable's success is attributed to its ability to integrate real-world perspectives into its clinical trials platform. Jena Daniels, the Vice President of Customer Value at Medable, emphasized the importance of patient experiences in shaping their technology and solutions. Through active collaboration with patients, Medable has established itself as a company that genuinely values the voices of those it serves.
Collaborative Efforts with Patient Advocacy
Furthermore, a strategic partnership with Rare Patient Voice has expanded Medable's reach, adding over 1,600 additional patients who have previously participated in decentralized or hybrid trials. This collaboration ensures that diverse patient insights are reflected in Medable's offerings, thus improving the clinical trial experience for a variety of populations.
Voices from the Community
Wes Michael, the President of Rare Patient Voice, applauded Medable for their commitment to excellence in patient engagement. The cooperative endeavor helps foster access to patients willing to share their experiences in clinical research. Such engagements have led to improved understanding and methodologies, ultimately benefiting clinical trial processes.
Participants like Karen Utley, a long-time member of Medable's PCN, echo the sentiments of many in the community. Her daughter, who has participated in a decentralized trial, was able to navigate treatment during the challenges posed by the COVID-19 pandemic. Karen highlighted Medable's attentiveness to patient needs, stating that their commitment to enhancing trial experiences is evident through their solutions.
Ongoing Dedication to Innovation
The pursuit of improved clinical trial experiences does not stop with patient engagement. Medable also places notable importance on gathering feedback from clinical trial sites. By listening to site personnel, Medable seeks to alleviate operational burdens and enhance the overall focus on patient care.
As a highly recognized player in the industry, Medable has been noted in the top 8% of software companies as per the recent Inc. 5000 list. Their software-as-a-service platform is currently being utilized in over 300 decentralized and hybrid trials across 60 countries, benefitting more than one million participants globally. The efficiency achieved through Medable's approach is evidenced by the drastic improvements in trial enrollments and cost reduction metrics.
Future Prospects and Impact
Looking ahead, studies suggest that decentralized trials, like those facilitated by Medable, can yield significant financial benefits. On average, these trials can deliver returns ranging from five to 13 times the investment, offering a potential return on investment of around $10 million in Phase II and $39 million in Phase III trials.
About Medable
Medable is on a mission to accelerate the availability of effective therapies to patients in need. Its cutting-edge digital clinical trials platform promotes speed, scale, and patient access in medical research, helping to bring crucial treatments to the forefront. Recognized as the Best Digital Health Solution by the Galien Foundation, Medable's initiatives are creating meaningful change in the healthcare landscape.
With a track record of involvement in nearly 400 trials globally, Medable is reshaping the future of clinical research by bringing patients faster access to solutions that may change their lives.
Frequently Asked Questions
What is Medable known for?
Medable is recognized for its innovative platform that enhances patient engagement in clinical trials, significantly improving the research experience.
What was Medable's recent achievement?
Medable was named a 'Trailblazer' by Everest Group for its outstanding performance in patient engagement in clinical research.
How does Medable ensure patient voices are heard?
Through the Patient Caregiver Network, Medable actively incorporates real patient experiences and feedback into its clinical trial platform.
What are the benefits of decentralized clinical trials?
Decentralized trials can achieve substantial financial returns, with reports suggesting benefits from five to 13 times the investment made.
Where is Medable headquartered?
Medable is a privately held company headquartered in Palo Alto, California, focused on transforming clinical research through technology.
